Popular weight-loss drugs may help protect against a deadly disease, doctor says

GLP-1 medications person transformed diabetes and obesity treatment, but emerging probe suggests their benefits could widen acold beyond those purposes — perchance adjacent aiding successful crab prevention and survival.

Dr. Loren Rourke, a Texas-based board-certified bosom crab surgeon, writer and speaker, said increasing probe suggests glucagon-like peptide-1 (GLP-1) medications — including Ozempic and Wegovy — whitethorn beryllium associated with a little hazard of crab diagnoses and recurrence. 

She pointed to findings presented astatine the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting successful Chicago, wherever researchers reported an relation betwixt GLP-1 usage and little bosom crab recurrence rates, arsenic good arsenic a imaginable relation successful preventing the disease.

MILLIONS COULD GAIN EASIER ACCESS TO POPULAR PEPTIDES AFTER FDA PANEL VOTE

However, she noted that the grounds remains observational and can’t beryllium that the drugs trim crab risk.

Emerging probe suggests that GLP-1 medications could assistance successful crab prevention and survival. (iStock)

"So these aren’t studies that, unfortunately, patients tin latch onto, telephone their doc and say, ‘I privation to get connected a GLP-1 close present to trim my hazard of bosom crab oregon marque my bosom crab better,’" Rourke told Fox News Digital. "However, what it did bash was radiance the airy connected GLP-1s and that relationship."

The crab connection

The main crushed that GLP-1s whitethorn assistance successful crab prevention, according to Rourke, is that the drugs beforehand value nonaccomplishment and trim chronic inflammation.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"GLP-1s origin a alteration successful your BMI. They origin value reduction," she told Fox News Digital. "We cognize that a little BMI equals a amended prognosis with bosom cancer."

In particular, post-menopausal women who are struggling with value summation could get an other benefit, the doc said. (iStock)

"So if the secondary effect of taking a GLP-1 means you’re going to suffer weight, past that’s a benefit, due to the fact that we cognize you’re going to bash amended with bosom cancer."

Diabetes and obesity medications tin besides little estrogen accumulation associated with excess assemblage fat, the surgeon noted.

CLICK HERE FOR MORE HEALTH STORIES

"The much abdominous you have, the higher your estrogen production," Rourke said. "You’re benignant of bathing your assemblage successful estrogen, truthful to speak. So it intuitively makes consciousness that we are seeing this correlation oregon association."

GLP-1s besides alteration the inflammatory authorities successful which crab thrives, the surgeon noted.

"The much abdominous we have, the higher your estrogen production."

"So if it’s fixing the wide chronic inflammation of the body, that’s going to assistance for a batch of reasons," she said.

"I deliberation this is going to widen beyond bosom cancer, but we request to get that technological impervious of a nonstop origin — is this conscionable an relation oregon a correlation?"

More probe needed

Rourke emphasized that researchers person not yet proven that GLP-1 medications straight impact bosom crab cells.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"But this survey has present garnered capable attention, involvement and technological hypotheses that the enactment is getting started for the randomized controlled trials that we’re each waiting for — and past we tin enactment upon those."

The main crushed that GLP-1s whitethorn assistance successful crab prevention is that the drugs beforehand value nonaccomplishment and trim chronic inflammation, according to a doctor. (iStock)

To patients who are considering starting GLP-1s, Rourke offered the pursuing advice.

"My bottom-line connection connected this 1 is, if you person an elevated BMI, you’re trying to suffer weight, you’ve tried a steadfast diet, you’ve tried to exercise, and you’re not winning that fight, see GLP-1s, and you’re going to get a secondary benefit."

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

In particular, post-menopausal women who are struggling with value summation could get an other benefit, Rourke added, but she urges them to "call their doc and person that one-on-one conversation."